BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8149967)

  • 1. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
    Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
    Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.
    Merkenschlager M; Buck D; Beverley PC; Sattentau QJ
    J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK; Sieh M; Pious DA; Reinherz EL
    Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes.
    Kansas GS; Cambier JC; Tedder TF
    Eur J Immunol; 1992 Jan; 22(1):147-52. PubMed ID: 1730248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
    Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
    J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of CD4 with HIV-1 gp120.
    Silberman SL; Goldman SJ; Mitchell DB; Tong AT; Rosenstein Y; Diamond DC; Finberg RW; Schreiber SL; Burakoff SJ
    Semin Immunol; 1991 May; 3(3):187-92. PubMed ID: 1888898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
    Jabado N; Le Deist F; Fisher A; Hivroz C
    Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
    Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
    Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
    Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
    J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ class I-restricted T cells specific for HIV gp160 315-329.
    Moore RL; Fox BS
    Cell Immunol; 1994 Mar; 154(1):43-53. PubMed ID: 7907008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.